3 documents found, page 1 of 1
Pain Reduction in Adults with Limb Spasticity Following Treatment with Incobotu...
Wissel, J; Camões-Barbosa, A; Comes, G; Althaus, M; Scheschonka, A; Simpson, DSome studies have shown that incobotulinumtoxinA reduces spasticity-associated pain, but further evidence is needed. This exploratory analysis pooled pain-relief data from six Phase 2 or 3 studies of incobotulinumtoxinA (four placebo-controlled studies) for treating upper limb spasticity in adults. Spasticity-associated pain was assessed at baseline and 4 weeks post incobotulinumtoxinA injection using the disab...
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Pos...
Camões-Barbosa, A; Ribeiro, I; Medeiros, LBotulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin. Contralateral weakness after botulinum toxin A treatment is a rarely reported adverse effect. We report the case of a 33-year-old female who had been receiving regular injec...
Afasia y depresión post-ictus: una relación predictiva
Camões-Barbosa, A; Sequeira-Medeiros, L; Duarte, N; Morais, J; Mendes, M; Meneses, CIntroducción/objetivos: La depresión se ha mostrado como la complicación psiquiátrica postictus más común, y la que se asocia con un pronóstico peor. Todavía existe incerteza en cuanto a su etiología y factores de riesgo. Algunos factores son reconocidos: gravedad del ictus, grado de discapacidad y déficit cognitivo. Por ello, es urgente definir nuevos factores que faciliten un diagnóstico temprano, lo cual pue...